Famke L. Schneiders

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

David A. Palma, Robert Olson, Stephen Harrow et al. · BMC Cancer · 2019 · 250 citations · Full text

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Robert Olson, Lindsay Mathews, Mitchell Liu et al. · BMC Cancer · 2020 · 115 citations · Full text

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

Renée C.G. de Bruin, John P. Veluchamy, Sinéad M. Lougheed et al. · OncoImmunology · 2017 · 82 citations · Full text

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation

Berbel J.R. Sluijter, Mari F.C.M. van den Hout, Bas D. Koster et al. · Cancer Immunology Research · 2015 · 61 citations

Real‐time analysis of the cancer genome and fragmentome from plasma and urine cell‐free DNA using nanopore sequencing

Ymke van der Pol, Normastuti Adhini Tantyo, Nils Evander et al. · EMBO Molecular Medicine · 2023 · 48 citations · Full text